Private Label Omega-3 Fish Oil Enteric Coated

EPA and DHA are long-chain marine omega-3 fatty acids incorporated into cell-membrane phospholipids and used as substrates for signaling molecules, including specialized pro-resolving mediators. DHA is especially concentrated in neural and retinal membranes, while EPA contributes to eicosanoid and resolvin pathways. Enteric coating changes where the softgel opens in the gastrointestinal tract; it should not be described as increasing potency unless comparative release or bioavailability testing supports that claim.

To ensure that Cpack Manufacturing is providing a differentiated Omega-3 Fish Oil product, the stock formula uses an enteric-coated dosage form intended for delayed gastric release. Final EPA, DHA, total omega-3, fish-oil dose, and coating-performance specifications should follow the current finished-product documentation rather than be inferred from other Cpack fish-oil SKUs.

The main benefits provided by our Private Label Omega-3 Fish Oil Enteric Coated supplements are as follows:

• Fish Oil — Marine lipid source of EPA and DHA; exact fish-oil and total omega-3 amounts should follow the current stock formula specification.
• EPA — Eicosapentaenoic acid is incorporated into membranes and serves as a substrate for eicosanoids and E-series specialized pro-resolving mediators.
• DHA — Docosahexaenoic acid is a major structural omega-3 fatty acid in neural and retinal membranes and a precursor for D-series resolving mediators.
• Membrane Phospholipids — EPA and DHA can replace other fatty acids within phospholipids, influencing membrane composition and downstream lipid signaling.
• Enteric Coating — An acid-resistant coating delays shell opening through the stomach and targets release farther along the gastrointestinal tract.
• Oxidation Control — Marine omega-3 oils are oxidation-sensitive, making peroxide, anisidine, and related quality controls important to finished-product integrity.